摘要
高鼻羚羊在中国已30年未见踪迹,被列为国家一级保护动物。中国对高鼻羚羊的利用,以传统的羊角入药为主,并早在距今1800年前就有记载。据调查,中国现有40余种中药含有高鼻羚羊角的成份,每年约消耗羊角6000kg,但这些羊角不是依赖进口,而是源于中国原有的库存。目前,中国正通过控制贸易,实施再引入工程,开展中药替代品研究等手段来减少对高鼻羚羊角的利用,并设法恢复该物种种群。
For nearly 3 decades, it has been very difficult in China to find the wild Saiga (Saiga tatarica), a national first-class protected animal. Traditionally, Saiga antler was used as the raw material in Chinese medicine, which was recorded as early as 1800 years ago. According to a recent survey, there are still about 40 kinds of Chinese medicine containing different proportions of Saiga antler requiring about 6000 kg of antler annually. However,the majority of antler required comes mainly from China's own stock, rather than from imported antlers. At present, China is strictly controlling the use of Saiga antler and trying to restore Saiga populations through measures of trade limitation, individual reintroduction and use of medicine substitutes.
